- IBM (IBM.US): Signs a multi-year $240 million agreement with Together AI to deploy NVIDIA HGX B300 clusters on IBM Cloud.
- CME Group: 24-hour around-the-clock trading for silver will launch on September 11.
- CME Group will expand round-the-clock trading to include 100-ounce silver futures.
- Big Sky Industrial 2Q Production Was 33,747 Barrels of Oil Equivalent >BSIN
- US Stock Market Preview | All Three Major Index Futures Rise, Nvidia (NVDA.US) Teams Up with Wall Street to Leverage $500 Billion, Yen Approaches 160 Again
- Egypt's Ministry of Energy: Egypt will launch the Meleiha gas plant next month.
- CME Group to Launch 24-Hour Silver Trading on September 11
- Theriva Biologics 2Q Loss $3.22M >TOVX
- TRX staking declines as TRON’s Q2 USDT transfers hit $2.1T: Can demand beat supply?
- Reuters survey: The yield on the US two-year Treasury note is expected to drop to 4.07% within three months, 3.92% within six months, and 3.80% within one year (the July survey indicated 4.00%, 3.90%, and 3.85% respectively).
- Reuters survey: 18 out of 22 bond strategists say that over the next three months, the yield on the US 10-year Treasury bond is more likely to exceed expectations than fall below them.
- Reuters survey: The yield on 10-year US Treasury bonds is expected to fall to 4.50% in three months and remain at that level for the following three months, dropping to 4.34% after one year (July survey figures were 4.48%, 4.48%, and 4.39%, respectively).
- Coya Therapeutics 2Q Rev $243,745 >COYA
- LB Pharmaceuticals 2Q Research and Development Expenses $44.1M >LBRX
- Analyst Who Called $3.37 XRP Top States What to Expect If XRP Breaks $1.01
- Fort Technology Signs Agreements For The Acquisition Of Logia USA - Fuel Integrity Solutions For Data Centers Company >FORT.V
- LB Pharmaceuticals 2Q Loss/Shr $1.71 >LBRX
- Big Sky Industrial 2Q Loss/Shr 4c >BSIN
- Big Sky Industrial 2Q Loss $2.34M >BSIN
- Big Sky Industrial 2Q Rev $2.13M >BSIN
- Bitcoin decouples from software stocks, signaling investor shifts
- Foreign Media: After XRP Accounts Surpass 8 Million, the Top 1% Threshold Drops to 44,771 Tokens
- web3: XLM falls below key support, derivatives data weakens
- US Dollar: CPI keeps USD in tight ranges – OCBC
- Token Unlocks This Week: Why Supply Share Matters More Than Value
- Web3: Bitcoin falls below $64,000, ETFs turn to net outflows
- GBP/USD Price Forecast: Holds Descending Triangle breakout
- Qatar says Oman-Iran talks reach advanced stage
- A storage tank at Libya's main oil refinery was hit and caught fire.
- Neuronetics 2Q Loss $3.44M >STIM
- US Stock Movement | Beyond Meat Plunges 21% in Pre-market Trading
- $19 Billion AI Bet Backfires as Korean Retail Suffers Worst KOSPI Crash Since 2008
- Market News: The total assets under management in the German fund industry have surpassed €5 trillion for the first time.
- Nvidia’s $500B AI Infrastructure Push Could Deepen Divide With Decentralized Networks
- Breaking: National Bank of Canada Reveals Holdings In XRP ETF, Bitcoin ETFs
- Natural gas: European prices surge as LNG flows stall – ING
- Farewell to "K-shaped divergence"? PNC report: The gap in consumption between high- and low-income households in the U.S. will basically disappear by 2026, with the labor market as the key support
- The SEC will discuss a regulatory framework for crypto token issuance.
- From 1.5GW Reservation to $20 Billion Valuation Ambition: Singapore Data Center Operator DayOne Rushes for US IPO
- From 1.5GW Bookings to a $20 Billion Ambition: Singapore Data Center Operator DayOne Races Toward US IPO
- Egypt: MELEIHA Natural Gas Plant Project in the Western Desert to Begin Operations Next Month with a Daily Capacity of 100 Million Cubic Feet
- Bicara Names Jenn Larson CFO
- Neurogene 2Q Research & Development Expenses $25.5M >NGNE
- Neurogene 2Q Loss/Shr $1.53 >NGNE
- Intensity Therapeutics 2Q Loss $3.01M >INTS
- Intensity Therapeutics 2Q Loss/Shr $1.11 >INTS
- Trump Media & Technology Group stock wobbles after $238M quarterly loss
- Bitget Protection Fund valuation climbs to $351M as Bitcoin rallies in July
- Chainlink crypto nears 9.48 resistance as RSI hits overbought 77.61
- Bicara Therapeutics 2Q Loss/Shr 82c >BCAX
- Zura Bio 2Q Loss $26.3M >ZURA
- Ambiq Micro 2Q Loss/Shr 32c >AMBQ
- Ambiq Micro 2Q Sales $33.9M >AMBQ
- Zura Bio Expects Existing Cash and Cash Equivalents Sufficient to Support Planned Ops Through at Least End of 2028 >ZURA
- Sagimet Biosciences 2Q Loss/Shr 26c >SGMT
- Stellar price risks a deeper correction toward $0.142
- SEC Tees Up New Crypto Rulebook As XRP Wobbles
- Babcock & Wilcox Shares Gain After Signing of Data-Center Power Agreement
- Japanese Yen: Wider range with intervention support against US Dollar – HSBC
- Top 3 Price Prediction: Bitcoin (BTC), Ethereum (ETH), XRP (XRP)
- Deutsche Bank economists anticipate that U.S. gasoline prices will fall by about 2% in July, with both headline and core CPI year-on-year growth rates dropping by approximately 0.1%. The former is expected to decrease from 3.53% to 3.45%, and the latter from 2.59% to 2.51%.
- Brent crude oil fell by about $1 in the short term, hitting a low of $87.17 per barrel.
- The main contract of Nymex WTI crude oil futures just broke through the $82.00 per barrel mark, last quoted at $81.98 per barrel, down 0.18% on the day.
- US Dollar Index Price Forecast: A break above 100.00 would confirm a double bottom
- Correct: Pet Valu Holdings 2Q EPS C$0.37 >PET.T
- Correct: Pet Valu Holdings 2Q Rev C$290.7M >PET.T
- Milady memecoin whales sitting on paper profits worth more than $20 million
- Middleby Sees FY26 Adj EPS $6.73-Adj EPS $6.89 >MIDD
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- Middleby Sees 3Q Sales $620M-$640M >MIDD
- Harvard Bioscience Sees 2026 Revenue Growth of 3% to 5% >HBIO
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- Middleby Sees FY26 Sales $2.48B-$2.53B >MIDD
- Middleby Sees 3Q Adj EPS $1.67-Adj EPS $1.83 >MIDD
- Harvard Bioscience Sees 3Q Rev $21M-$22.6M >HBIO
- Xtant Medical Holdings Cuts 2026 View To Rev $99M-$103M >XTNT
- Hemab Therapeutics 2Q Research and Development Expenses $20.3M >COAG
- Fennec Pharmaceuticals 2Q EPS 5c >FRX.T
- Fennec Pharmaceuticals 2Q Rev $17.9M >FRX.T
- C4 Therapeutics 2Q Loss $23.6M >CCCC
- CVRx Says Verrastro Has More Than 30 Years of Medical Device Sales, Marketing Experience >CVRX
- Terrestrial Energy Reported 2Q Cash Burn of $6.4M, a Decrease of $1.5M Compared to 1Q >IMSR
- CalciMedica 2Q Research and Development Expenses $2.1M >CALC
- CalciMedica 2Q Loss/Shr 45c >CALC
- Terrestrial Energy 2Q Loss/Shr 9c >IMSR
- 908 Devices Narrows 2026 View To Rev $68.0M-$70.0M >MASS
- Aura Biosciences 2Q Loss/Shr 48c >AURA
- 908 Devices 2Q Loss/Shr 32c >MASS
- CVRx: Paul Verrastro to Assume Role of Interim Head of Sales, Effective Immediately >CVRX
- Dow Jones Top Company Headlines at 7 AM ET: Anthropic Tries to Shore Up Investor Confidence Ahead of Blockbuster IPO | Smithfield ...
- Prelude Therapeutics 2Q Rev $5.7M >PRLD
- Kardigan 2Q Loss/Shr $4.61 >KARD
- Xtant Medical Holdings 2Q Loss $9.41M >XTNT
- Middleby 2Q EPS $1.21 >MIDD
- C4 Therapeutics 2Q Loss/Shr 18c >CCCC
- Middleby 2Q Sales $875.5M >MIDD
- Xtant Medical Holdings 2Q Rev $23M >XTNT
- Middleby 2Q Adj EPS $2.35 >MIDD
